Osamu Iida
Overview
Explore the profile of Osamu Iida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
400
Citations
2266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimura K, Aedla R, Fuchino H, Iida O, Watanabe T
J Nat Med
. 2025 Mar;
PMID: 40075038
Immature Evodia fruits are used in herbal medicine for their analgesic properties; however, determining the appropriate time for harvesting these fruits remains challenging. Here, we investigated the growth characteristics and...
2.
Kanda T, Minamiguchi H, Iwami R, Iida O, Higuchi Y
J Arrhythm
. 2025 Mar;
41(2):e70030.
PMID: 40046264
High-resolution mapping with Ripple and LAM modules enabled precise identification of slow pathway ablation targets in a PLSVC patient. This novel approach overcame anatomical challenges, offering a more effective strategy...
3.
4.
Nakahashi T, Takahara M, Iida O, Kohsaka S, Soga Y, Horie K, et al.
Vasc Med
. 2025 Feb;
:1358863X251320113.
PMID: 39992160
Although bleeding is a common procedure-related adverse event following endovascular therapy (EVT), limited data exist regarding the procedural and anatomical factors associated with its complications in patients with lower-extremity artery...
5.
Yamazaki N, Sakata H, Iida O, Katayama T, Uhara H
Int J Clin Oncol
. 2025 Feb;
PMID: 39918770
Background: A BRAF inhibitor, encorafenib, combined with a MEK inhibitor, binimetinib, was approved in Japan in early 2019 for the treatment of BRAF V600-mutant, unresectable malignant melanoma based on results...
6.
Horie K, Takahara M, Iida O, Soga Y, Yamaoka T, Fujihara M, et al.
JACC Asia
. 2025 Jan;
5(1):119-121.
PMID: 39886194
No abstract available.
7.
Soga Y, Takahara M, Yamauchi Y, Iida O, Fujihara M, Kawasaki D, et al.
Circ J
. 2025 Jan;
PMID: 39880643
Background: Although revascularization is first-line therapy for chronic limb-threatening ischemia (CLTI), there are no established treatments for patients in whom revascularization is not (or is a poor) option, including CLTI...
8.
Suemitsu K, Iida O, Sato K, Miyamoto M, Murakami M, Toyoshima T, et al.
J Vasc Access
. 2025 Jan;
11297298251314065.
PMID: 39878210
Objective: This study aimed to evaluate the effectiveness of a drug-coated balloon (DCB) for the treatment of dysfunctional arteriovenous fistulas (AVFs) and to identify the risk factors associated with early...
9.
Kanda T, Minamiguchi H, Sakio T, Iwami R, Iida O, Higuchi Y
HeartRhythm Case Rep
. 2024 Dec;
10(11):775-779.
PMID: 39664659
No abstract available.
10.
Miwa K, Minamikawa R, Iida O, Furusho H, Yasuda T
Eur Heart J Case Rep
. 2024 Dec;
8(12):ytae631.
PMID: 39659474
Background: Drug-eluting therapies remarkably reduce the incidence of restenosis and have revolutionized endovascular strategies for femoropopliteal lesions in patients with peripheral artery disease, nevertheless, concerns have arisen over the risk...